The firm said that a strong start to the commercialization of its Liaison Plex platform also aided growth in its molecular diagnostics business.

"CLIA registration represents a significant step forward for ... Specializing in genomic, proteomic, immunoassay, and cell-based assay solutions, the company serves biopharmaceutical innovators with ...

Archimed has bought BioVendor, with plans to build and internationalize the Czech diagnostics company. Archimed sees ...

Bert Janssens takes the Europe spot and Eric Liu takes North America. Franzén, who succeeds Christian Sinding as CEO ...

The company’s CLIA-certified lab in Irvine ... “One of the key components of the test is a protease turnover assay for an enzyme that is atypically found in the pancreas, thus providing biological ...

Enhanced assay granted approval by New York State’s Clinical Lab Evaluation Program (CLEP) for patients with DLBCL clonoSEQ is the only DLBCL MRD ...

A study published in November in the American Journal of Clinical Pathology that Emerson co-authored validated the analyzer against the Sysmex XN Automated Hematology System and found that CytoChip's ...

The Business Research Company The Business Research Company's Vitamin Biomarkers Global Market Report 2025 – Market Size, Trends, And Forec ...

Esoteric Testing Market Research Report In 2022, the global esoteric testing market was valued at $24.2 billion and projected reach $68.5 b ...

The assay leverages the same powerful technology as prior versions ... is currently available for clinical use as a laboratory-developed test (LDT) performed at Adaptive's CLIA-certified lab in ...